The Poland Diabetes Devices Market is expected to witness growth from $132 Mn in 2022 to $238 Mn in 2030 with a CAGR of 7.65% for the forecasted year 2022-2030. Diabetes is more common in older people, so demand for diabetes devices is anticipated to increase as Poland's population ages. The market is segmented by type and by the end user. Some key players in this market include Skamex, SORIMEX, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
The Poland Cardiac Surgery Instruments Market is expected to witness growth from $12 Mn in 2022 to $21 Mn in 2030 with a CAGR of 7.05% for the forecasted year 2022-2030. Cardiovascular diseases are becoming more prevalent in Poland as the country's populace increases. Additionally, the older population has more complicated health problems, which increases the demand for cardiac surgery instruments in Poland. The market is segmented by type, application and by end user. Some key players in this market include Metrum Cryoflex, Skamex, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
The Poland healthcare insurance market is projected to grow from $11.75 Bn in 2022 to $21.83 Bn by 2030, registering a CAGR of 8.05% during the forecast period of 2022 - 2030. The main factors driving the growth would be the digital health marketplace, rising healthcare costs, government policies and Technological advancements. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Luxmed, PZU Zdrowie, Inter Polska, Medicover and Allianz.
The Poland-connected healthcare market is projected to grow from $384.89 Mn in 2022 to $2924.22 Mn by 2030, registering a CAGR of 28.85% during the forecast period of 2022 - 2030. The main factors driving the growth would be a shortage of medical professionals, increasing demand for healthcare services, technological advancements and government initiatives. The market is segmented by type, function and by application. Some of the major players include Comarch Healthcare, Asseco, StethoMe, Jutro Medical, Philips Healthcare and Siemens Healthcare.
Poland anti-aging therapeutics market is expected to witness growth from $4 Mn in 2022 to $12 Mn in 2030 with a CAGR of 16.98% for the year 2022-2030. The rising awareness about anti-aging therapeutics and recent technological advancements in Poland has led to market expansion. The Poland anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the major competitors in the market are Intelliseq, Pure Biologics, and NuSirt.
The Poland Biomaterials in Healthcare Market is expected to witness growth from $906 Mn in 2022 to $2522 Mn in 2030 with a CAGR of 13.65% for the forecasted year 2022-2030. Poland biomaterials manufacturers work with research organizations to create novel biomaterials or enhance existing ones. The market for biomaterials is expanding as a result of such collaboration that results in the creation of new products and invention. The market is segmented by type and by application. Some key players in this market include: NanoGroup S.A, Biovico, Matopat, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Poland's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $171 Mn in 2022 to $316 Mn in 2030 with a CAGR of 7.95% for the year 2022-2030. The increased prevalence of ADHD and the availability of novel therapeutic options for the treatment of ADHD in Poland are the major market drivers for the growth of the market. The Poland ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market are ALG Pharma, Techdow Pharma, and Noven Pharmaceuticals.
Poland 3D Printing Medical Device Market is expected to witness growth from $17 Mn in 2022 to $59 Mn in 2030 with a CAGR of 16.75% for the forecasted year 2022-2030. In Poland, Patients need medical devices that are specifically designed for their individual anatomical demands and medical requirements. The demand for 3D printing medical devices in Poland is being driven by manufacturers ability to create customised medical devices quickly and affordably. The market is segmented by application, by technology and by end user. Some key players in this market include: Braster S.A, Skamex, Stryker, Stratasys, GE Additive and Prodways Group.
Poland's oncology clinical trials market is projected to grow from $73.4 Mn in 2022 to $116.5 Mn by 2030, registering a CAGR of 5.95% during the forecast period of 2022-30. The market will be driven by the increased prevalence of cancer and a good regulatory framework. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG, Novartis International AG & Ryvu Therapeutics.
The Poland healthcare claims management market is projected to grow from $154.86 Mn in 2022 to $857.25 Mn by 2030, registering a CAGR of 23.85% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising demand for value-based care, the growing adoption of digital health solutions, and increasing healthcare expenditure and government initiatives. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Comarch, Minte, Crawford and Company, Infosys and Accenture.
By 2030, it is anticipated that the Poland Liver Cancer Therapeutics market will reach a value of $64.1 Mn from $17 Mn in 2022, growing at a CAGR of 18.1 % during 2022-2030. Liver Cancer Therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma Biologics, Adamed Group and Celon Pharma. The Liver Cancer Therapeutics market in Poland is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Poland Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
The Poland Neurology Clinical Trials market is projected to grow from $30.3 Mn in 2022 to $48.2 Mn by 2030, registering a CAGR of 5.95% during the forecast period of 2022 - 2030. The market will be driven by a skilled workforce, a supportive regulatory framework, and a relatively low cost of conducting research. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Inc., Pfizer Inc. & Novartis AG.
By 2030, it is anticipated that the Poland infectious disease therapeutics market will reach a value of $1012 Mn from $695 Mn in 2022, growing at a CAGR of 4.8% during 2022-2030. Infectious Disease Therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma Group, Selvita and Adamed Group. The Infectious Disease Therapeutics market in Poland is segmented into different therapeutic areas and different diseases type. The major factors affecting the Poland infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Poland.
Poland’s Artificial Intelligence (AI) in the diagnostics market is projected to grow from $5.8 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by an increasing number of organizations and industries investing in AI-powered diagnostic solutions and the rising demand for advanced diagnostic solutions. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Infermedica & Cardiomatics.
By 2030, it is anticipated that the Poland Nutrition and Supplements market will reach a value of $xx Bn from $2.21 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The nutrition and supplements market in Poland is primarily dominated by local players such as Walmark, Aflofarm Farmacja Polska, and Olimp Laboratories. The market for nutrition and supplements in Poland is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Poland nutrition and supplements market in Poland is segmented by Type, Product, application, and Distribution Channel.
The Poland Neurology Device Market is expected to witness growth from $73 Mn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The neurology devices market in Poland is expanding as a result of factors such as the prevalence of neurological conditions like dementia, Parkinson's disease, and stroke is rising in Poland as the population ages. As a result, the demand for neurology devices is rising. The market is segmented by product type and by the end user. Some key players in this market include Synektik, Skamex, Medtronic, Abbott Laboratories, GE Healthcare, Penumbra, and Boston Scientific.
The Poland patient engagement solutions market is projected to grow from $98.66 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, growing prevalence of chronic diseases, increasing healthcare expenditure and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Infermedica, Comarch Healthcare, Wolter Kluwer, Oracle and IBM.
By 2030, it is anticipated that the Poland HIV therapeutics market will reach a value of $xx Mn from $79.81 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Polpharma, Polfa Tarchomin, and Adamed. The market is driven by government policies and non-governmental organizations’ initiatives for the management of HIV infections in the country. The HIV therapeutics market in Poland is segmented by type, product, geography, end user, and distribution channel.
By 2030, it is anticipated that the Poland Dermatology drugs market will reach a value of $xx Mn from $98.6 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Centrum Medyczne Dermiq, Novoxidyl, and Ita-Test laboratory. The market is driven by government regulations, increasing the prevalence of disease, and health indicators in the country. The dermatology drug market in Poland is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
The Poland 3D Imaging market is projected to grow from $0.18 Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for effective diagnostic technologies and advances in imaging technology. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare.
The Poland Palliative care market is projected to grow from $75.86 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in the prevalence of chronic diseases, an aging population, and palliative care education. The market is segmented by service type and by the end user. Some of the major players include Caritas Pflege, Hospice Vorarlberg, St. Lazarus Hospice, and Warsaw Hospice for Children.
The Poland Cancer Pain Management market is projected to grow from $37.82 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be a rise in cancer cases, improvement in healthcare infrastructure, government initiatives, and advances in pain management technologies. The market is segmented by drug type and by disease. Some of the major players include Hasco-Lek, Mundipharma, Pfizer, Teva Pharmaceuticals, Abbott, and Sanofi.
The Poland home healthcare market was valued at $2.1 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $3.87 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by component and product. Some key players in this market are Specialized Senior Care, Mahoning Home Care, Wright Homecare Solutions, Caring Hearts of The Valley, and Answercare among others.
The Poland Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. This growth can be attributed to technological advancement and the rising adoption of EHR. The market is segmented by product, application, and end User. Some of the major players are Epic Systems, Allscripts, McKesson, Meditech, and others.
The Poland Bioinformatics market is projected to grow from $89.03 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be an as increasing prevalence of chronic disease, advances in technology, and the growing pharmaceutical industry. The market is segmented by technology and by application. Some of the major players include Ardigen (POL), genXone (POL), Ideas4biology (POL), Agilent Technologies, IBM Life Sciences, and Qiagen.